comprehensive -WSS

comprehensive

author：fashion 2025-09-28 21:06:13 - browse：443

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： ALS treatment from Biogen, Ionis fails in study

WSS

HHS suspends federal funding for EcoHealth Alliance

CVS is willing to dump 10% of its Medicare Advantage members

Grail spinoff by Illumina should end disastrous merger attempt

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Hospitals owned by private equity see complications spike 25%

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

leisure time

comprehensive

focus

After affirmative action ruling, medical educators look to 'holistic review'

David Ricks of Eli Lilly: best biopharma CEO of 2023

Medical leaders decry Supreme Court decision on affirmative action

SNAP should offer more nutrition education

Novavax promises a turnaround & Lilly roils the obesity market

Fertility clinic egg and embryo storage is a disaster

Wildfire smoke exposes gaps in outdoor worker protections

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Virtual care provider acquires bankrupt Pear's prescription apps

leisure time

The White House hikes tariffs on plastic syringes made in China

Can sheer will power keep patients alive in their dying hours?

SEC charges former device maker CEO with $41 million fraud

Hospitals owned by private equity see complications spike 25%

Drinking less cuts risk of oral cavity, esophageal cancer: Report

The White House hikes tariffs on plastic syringes made in China

focus

Wikipedia

hotspot

hotspot